Evidence map›Paper›PMID 34678158›Full record

ArticleStructure (London, England : 1993)2022

Structural evidence for visual arrestin priming via complexation of phosphoinositols.

Christopher L Sander, Jennings Luu, Kyumhyuk Kim, David Furkert, Kiyoung Jang, Joerg Reichenwallner, MinSoung Kang, Ho-Jun Lee, Bryan T Eger, Hui-Woog Choe and 5 more

Open access · greenAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Deceptive beauty of non-natural structures.Protein science : a publication of the Protein Society · 2026
    Review
  4. The Functional Role of Gate Loop Residues in Arrestin Binding to GPCRs.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Arrestins as Possible Drug Targets.Biomolecules & therapeutics · 2025
    Review
  7. Conformational dynamics of the active state of β-arrestin 1.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Structure and self-association of Arrestin-1.Journal of structural biology · 2025
    Review
  10. Article
  11. Article
  12. Arrestins: A Small Family of Multi-Functional Proteins.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Article
  15. Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibition.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Review
  17. The Role of Arrestin-1 Middle Loop in Rhodopsin Binding.International journal of molecular sciences · 2022
    Article
  18. Solo vs. Chorus: Monomers and Oligomers of Arrestin Proteins.International journal of molecular sciences · 2022
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Christopher L SanderDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Ophthalmology and the Gavin Herbert Eye Institute, University of California, Irvine, CA 92697, USA.
Jennings LuuDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Ophthalmology and the Gavin Herbert Eye Institute, University of California, Irvine, CA 92697, USA.
Kyumhyuk KimDepartment of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.
David FurkertLeibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Strasse 10, 13125 Berlin, Germany.
Kiyoung JangDepartment of Lifestyle Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea.
Joerg ReichenwallnerDepartment of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.
MinSoung KangDepartment of Lifestyle Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea; Thin Film Materials Research Center, Korea Research Institute of Chemical Technology (KRICT), 141 Gajeong-ro, Daejeon 34114, Republic of Korea.
Ho-Jun LeeDepartment of Ophthalmology and the Gavin Herbert Eye Institute, University of California, Irvine, CA 92697, USA; Research Service, VA Long Beach Healthcare System, Long Beach, CA 90822, USA.
Bryan T EgerDepartment of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada.
Hui-Woog ChoeDepartment of Chemistry, Jeonbuk National University, Jeonju 54896, Republic of Korea.
Dorothea FiedlerLeibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Strasse 10, 13125 Berlin, Germany.
Oliver P ErnstDepartment of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
Yong Ju KimDepartment of Lifestyle Medicine, Jeonbuk National University, Iksan 54596, Republic of Korea; Department of Oriental Medicine Resources, College of Environmental and Bioresource Sciences, Jeonbuk National University, Iksan 54596, Republic of Korea.
Krzysztof PalczewskiDepartment of Ophthalmology and the Gavin Herbert Eye Institute, University of California, Irvine, CA 92697, USA; Department of Chemistry and Molecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA; Department of Physiology & Biophysics, University of California, Irvine, CA 92697, USA.
Philip D KiserDepartment of Ophthalmology and the Gavin Herbert Eye Institute, University of California, Irvine, CA 92697, USA; Department of Physiology & Biophysics, University of California, Irvine, CA 92697, USA; Research Service, VA Long Beach Healthcare System, Long Beach, CA 90822, USA. Electronic address: pkiser@uci.edu.
University of California, Irvine · USUniversity of Toronto · CAJeonbuk National University · KRLeibniz-Forschungsinstitut für Molekulare Pharmakologie · DEKorea Research Institute of Chemical Technology · KR

Funding

X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Vivian Stojanoff · 2019 to 2026
$38.6M
User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI STEVEN E EALICK · 2018 to 2026
$34.2M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
X-ray Absorption Spectroscopy (XAS) pp.711-759P41GM103393 · NIGMS · STANFORD UNIVERSITY · PI HODGSON, KEITH O · 2012 to 2019
$30.6M
TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
STRUCTURAL STUDIES OF ARRESTINSR01EY009339 · NEI · UNIVERSITY OF WASHINGTON · PI KISER, PHILIP DAVID, PALCZEWSKI, KRZYSZTOF · 1992 to 2025
$16.0M
Novel therapies to inhibit Diabetic RetinopathyR24EY024864 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KERN, TIMOTHY S · 2015 to 2019
$8.1M
Use of systems pharmacology to prevent rod and cone photoreceptor degenerationR24EY027283 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI PALCZEWSKI, KRZYSZTOF · 2017 to 2021
$7.9M
RESOURCE/SERVICE CORE C - MOLECULAR INFORMATICS MODULEP30EY025585 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI BELA ANAND-APTE · 2016 to 2026
$7.7M
VISUAL SCIENCES TRAINING PROGRAMT32EY007157 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Johannes Friedrich von Lintig · 2000 to 2026
$5.5M
Identification of novel phosphodiesterase (PDE)-modulating compounds and characterization of associated cytoprotective pathways in lightdamagedretinaF30EY031566 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI LUU, JENNINGS C · 2021 to 2024
$209k
BLRD VA I01 BX004939CIHR PJT-159464NEI NIH HHS F30 EY031566NEI NIH HHS P30 EY011373NEI NIH HHS P30 EY025585NEI NIH HHS R01 EY009339NEI NIH HHS R24 EY024864NEI NIH HHS R24 EY027283NEI NIH HHS T32 EY007157NIGMS NIH HHS P30 GM124165NIGMS NIH HHS P30 GM133893NIGMS NIH HHS P41 GM103393NIGMS NIH HHS P41 GM111244NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Visual arrestin (Arr1) terminates rhodopsin signaling by blocking its interaction with transducin. To do this, Arr1 translocates from the inner to the outer segment of photoreceptors upon light stimulation. Mounting evidence indicates that inositol phosphates (InsPs) affect Arr1 activity, but the Arr1-InsP molecular interaction remains poorly defined. We report the structure of bovine Arr1 in a ligand-free state featuring a near-complete model of the previously unresolved C-tail, which plays a crucial role in regulating Arr1 activity. InsPs bind to the N-domain basic patch thus displacing the C-tail, suggesting that they prime Arr1 for interaction with rhodopsin and help direct Arr1 translocation. These structures exhibit intact polar cores, suggesting that C-tail removal by InsP binding is insufficient to activate Arr1. These results show how Arr1 activity can be controlled by endogenous InsPs in molecular detail.

Indexed as

AnimalsArrestinCattleCrystallography, X-RayInositol PhosphatesMiceModels, MolecularProtein ConformationProtein DomainsRhodopsinSequence Analysis, RNASingle-Cell AnalysisArrestinInositol PhosphatesRhodopsin(1,4,5) myo-D-inositol triphosphatearrestincrystal structureGPCRG protein-coupled receptorInsP(3)InsP(6)myo-D-inositol hexakisphosphatephospholipase Cphotoreceptorphototransductionretinavision

Identifiers

PMID34678158
PMCPMC8818024
OpenAlexW3205834419

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.